Epilepsy Devices Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932378

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932378

The global Epilepsy Devices market, valued at $[specific amount] million in 2020, is projected to reach $[specific amount] million by 2028, with a compound annual growth rate (CAGR) of 8.5% from 2021 to 2028. This growth is driven by a combination of macro and microeconomic factors, including the rising incidence of epilepsy, which fuels demand for advanced epilepsy management solutions.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Product Type (Conventional Devices, Wearable Devices, Others)
By End-Users (Hospitals & Clinics, Home Care Settings, Others)

Key players

Natus Medical
Koninklijke Philips
Medtronic
Nihon Kohden
PulseGuard International Ltd.
Masimo Corporation
Empatica, Inc.
Abbott Laboratories
LivaNova PLC
Compumedics

Chapter 1. Executive Summary
Chapter 2. Scope of The Study: 2.1. Market Definition; 2.2. Scope of The Study; 2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends: 4.1. Supply/ Value Chain Analysis; 4.2. Porter’s Five Forces Analysis; 4.2.1. Threat of New Entrants; 4.2.2. Bargaining Power of Buyers; 4.2.3. Bargaining Power of Suppliers; 4.2.4. Threat of Substitutes; 4.2.5. Industry Rivalry; 4.3. Impact of COVID-19 on Epilepsy Devices Market; 4.3.1. Impact on Market Size; 4.3.2. End User Trend, Preferences and Budget Impact; 4.3.3. Regulatory Framework/Government Policies; 4.3.4. Key Players Strategy to Tackle Negative Impact; 4.3.5. Opportunity Window
Chapter 5. Market Dynamics: 5.1. Introduction; 5.2. DRO Analysis; 5.2.1. Drivers; 5.2.2. Restraints; 5.2.3. Opportunities
Chapter 6. Global Epilepsy Devices Market, By Product Type: 6.1. Introduction; 6.2. Conventional Devices; 6.3. Wearable Devices; 6.4. Others
Chapter 7. Global Epilepsy Devices Market, By End-Users: 7.1. Introduction; 7.2. Hospitals & Clinics; 7.3. Home Care Settings; 7.4. Others
Chapter 8. Global Epilepsy Devices Market, By Region: 8.1. Introduction; 8.2. North America; 8.2.1. Introduction; 8.2.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.2.3. Market Size and Forecast, By Country, 2020 - 2028; 8.2.4. Market Size and Forecast, By Product Type, 2020 - 2028; 8.2.5. Market Size and Forecast, By End-Users, 2020 – 2026; 8.2.6. US; 8.2.6.1. Introduction; 8.2.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.2.6.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.2.6.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.2.7. Canada; 8.2.7.1. Introduction; 8.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.2.7.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.2.7.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.3. Europe; 8.3.1. Introduction; 8.3.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.3. Market Size and Forecast, By Country, 2020 - 2028; 8.3.4. Market Size and Forecast, By Product Type, 2020 - 2028; 8.3.5. Market Size and Forecast, By End-Users, 2020 – 2026; 8.3.6. Germany; 8.3.6.1. Introduction; 8.3.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.6.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.3.6.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.3.7. France; 8.3.7.1. Introduction; 8.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.7.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.3.7.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.3.8. UK; 8.3.8.1. Introduction; 8.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.8.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.3.8.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.3.9. Italy; 8.3.9.1. Introduction; 8.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.9.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.3.9.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.3.10. Rest of Europe; 8.3.10.1. Introduction; 8.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.3.10.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.3.10.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.4. Asia-Pacific; 8.4.1. Introduction; 8.4.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.3. Market Size and Forecast, By Country, 2020 - 2028; 8.4.4. Market Size and Forecast, By Product Type, 2020 - 2028; 8.4.5. Market Size and Forecast, By End-Users, 2020 - 2028; 8.4.6. China; 8.4.6.1. Introduction; 8.4.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.6.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.4.6.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.4.7. India; 8.4.7.1. Introduction; 8.4.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.7.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.4.7.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.4.8. Japan; 8.4.8.1. Introduction; 8.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.8.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.4.8.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.4.9. South Korea; 8.4.9.1. Introduction; 8.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.9.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.4.9.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.4.10. Rest of Asia-Pacific; 8.4.10.1. Introduction; 8.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.4.10.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.4.10.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.5. Rest of The World (RoW); 8.5.1. Introduction; 8.5.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.5.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.5.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.5.5. Market Size and Forecast, By Region, 2020 - 2028; 8.5.6. South America; 8.5.6.1. Introduction; 8.5.6.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.5.6.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.5.6.4. Market Size and Forecast, By End-Users, 2020 - 2028; 8.5.7. Middle East and Africa; 8.5.7.1. Introduction; 8.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends; 8.5.7.3. Market Size and Forecast, By Product Type, 2020 - 2028; 8.5.7.4. Market Size and Forecast, By End-Users, 2020 - 2028
Chapter 9. Competitive Landscape: 9.1. Introduction; 9.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
Chapter 10. Company Profiles: 10.1. Natus Medical; 10.1.1. Business Overview; 10.1.2. Financial Analysis; 10.1.3. Product Portfolio; 10.1.4. Recent Development and Strategies Adopted; 10.1.5. SWOT Analysis; 10.2. Koninklijke Philips; 10.2.1. Business Overview; 10.2.2. Financial Analysis; 10.2.3. Product Portfolio; 10.2.4. Recent Development and Strategies Adopted; 10.2.5. SWOT Analysis; 10.3. Medtronic; 10.3.1. Business Overview; 10.3.2. Financial Analysis; 10.3.3. Product Portfolio; 10.3.4. Recent Development and Strategies Adopted; 10.3.5. SWOT Analysis; 10.4. Nihon Kohden; 10.4.1. Business Overview; 10.4.2. Financial Analysis; 10.4.3. Product Portfolio; 10.4.4. Recent Development and Strategies Adopted; 10.4.5. SWOT Analysis; 10.5. PulseGuard International Ltd.; 10.5.1. Business Overview; 10.5.2. Financial Analysis; 10.5.3. Product Portfolio; 10.5.4. Recent Development and Strategies Adopted; 10.5.5. SWOT Analysis; 10.6. Masimo Corporation; 10.6.1. Business Overview; 10.6.2. Financial Analysis; 10.6.3. Product Portfolio; 10.6.4. Recent Development and Strategies Adopted; 10.6.5. SWOT Analysis; 10.7. Empatica, Inc.; 10.7.1. Business Overview; 10.7.2. Financial Analysis; 10.7.3. Product Portfolio; 10.7.4. Recent Development and Strategies Adopted; 10.7.5. SWOT Analysis; 10.8. Abbott Laboratories; 10.8.1. Business Overview; 10.8.2. Financial Analysis; 10.8.3. Product Portfolio; 10.8.4. Recent Development and Strategies Adopted; 10.8.5. SWOT Analysis; 10.9. LivaNova PLC; 10.9.1. Business Overview; 10.9.2. Financial Analysis; 10.9.3. Product Portfolio; 10.9.4. Recent Development and Strategies Adopted; 10.9.5. SWOT Analysis; 10.10. Compumedics; 10.10.1. Business Overview; 10.10.2. Financial Analysis; 10.10.3. Product Portfolio; 10.10.4. Recent Development and Strategies Adopted; 10.10.5. SWOT Analysis
Chapter 11. Key Takeaways